InterCure Ltd. (INCR) Stock
Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks
InterCure Ltd. (INCR) closed at USD 4.69 on 2026-10-14, a change of -34.9 % over the past year, with a market capitalization of USD 69.77M.
InterCure Ltd. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 4.69 |
| 2026-10-13 | 5.03 |
| 2026-10-12 | 4.95 |
| 2026-10-09 | 5.17 |
| 2026-10-08 | 5.03 |
| 2026-10-07 | 5.13 |
| 2026-10-06 | 5.32 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
InterCure Ltd. key figures
- Previous close
- USD 4.69 (2026-10-14)
- 1-year change
- -34.9 %
- Market cap
- USD 69.77M
- Enterprise value
- n/a
- P/E ratio (trailing)
- -4.90
- P/E ratio (forward)
- -3.14
- EPS (trailing)
- -0.95
- EPS (forward)
- -1.48
- PEG ratio
- n/a
- Price to book
- 0.61
- Revenue growth
- 23.9 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.60
- Employees
- 285
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for InterCure Ltd. and compare it with other stocks.
Analyze INCRAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell InterCure Ltd. shares.